Ceftriaxone, 1 g 50 pcs
€36.05 €31.25
Out of stock
(E-mail when Stock is available)
Ceftriaxone is a third-generation broad-spectrum cephalosporin antibiotic. It acts bactericidally by inhibiting cell membrane synthesis of microorganisms. In vitro suppresses growth of most gram-positive and gram-negative bacteria. Resistant against b-lactamases.
Indications
Sepsis, Vaginal infections, Pyelonephritis, Lung inflammation (pneumonia), Skin infections
Infectious and inflammatory diseases caused by ceftriaxone-sensitive microorganisms, including. Peritonitis, sepsis, meningitis, cholangitis, gallbladder empyema, shigellosis, salmonellosis, pneumonia, lung abscess, pleural empyema, pyelonephritis, infections of bones, joints, skin and soft tissue, genitals, infected wounds and burns.
Prevention of postoperative infection.
Active ingredient
Ceftriaxone
How to take, the dosage
Ceftriaxone is administered v/m or intravenously (by trickle or drip). For adults and children over 12 years of age the average daily dose is 1-2 g ceftriaxone once daily. In severe cases or in cases of infections caused by moderately sensitive pathogens, the daily dose may be increased to 4 g (2 g twice daily).
Interaction
Ceftriaxone and aminoglycosides are synergistic against many Gram-negative bacteria.
Special Instructions
The drug is prescribed with caution to newborns (including prematurely born) due to the high risk of hyperbilirubinemia, ulcerative colitis.
Contraindications
Hypersensitivity to ceftriaxone; pregnancy (I trimester).
Side effects
Allergic reactions: about 1% – urticaria, fever, chills, eosinophilia, rash, itching, exanthema, allergic dermatitis, erythema exudative multiforme, edema, anaphylactic shock. Digestive system: nausea, vomiting, stomatitis, glossitis, diarrhea, pseudomembranous enterocolitis, cholestasis, increased liver transaminases activity, hyperazotemia, hypercreatininemia, increased urea. CNS disorders: headache, dizziness. Blood system: leukopenia, neutropenia, granulocytopenia, thrombocytopenia, hemolytic anemia. Local reactions: when administered intravenously – phlebitis, soreness along the vein, when administered intravenously – soreness at the injection site. Other: superinfection (including candidomycosis, genital mycosis); oliguria, hypocoagulation.
Overdose
Treatment: symptomatic. Hemodialysis and peritoneal dialysis are not effective.
Weight | 0.220 kg |
---|---|
Shelf life | 2 years |
Conditions of storage | In a dry, light-protected place at a temperature not exceeding 25 °C |
Manufacturer | Kraspharma PJSC, Russia |
Medication form | Powder for preparation of solution |
Brand | Kraspharma PJSC |
Other forms…
Related products
Buy Ceftriaxone, 1 g 50 pcs with delivery to USA, UK, Europe and over 120 other countries.